A Study to Compare SB12 (Proposed Eculizumab Biosimilar) to Soliris in Subjects With Paroxysmal Nocturnal Haemoglobinuria
Clinical trial NCT04058158 · COMPLETED
Trial details
- NCT number
- NCT04058158
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-07
- Primary completion
- 2021-09-21
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.